Tobias

The frenzy surrounding potential AI IPOs from SpaceX, Anthropic, and OpenAI is intense. While SpaceX is valued at $1.77 trillion, Anthropic is a key focus. Its confidential IPO filing and $965 billion valuation hinge on its gross margin, a critical, undisclosed metric. Success will test investor appetite for frontier AI, impacting private competitors and enterprise AI cost valuations. This could mark a historic IPO cycle, or an expensive lesson in narrative versus fundamentals.

SoftBank Group shares dropped over 11% following a U.S. tech sell-off driven by profit-taking. Despite strong year-to-date gains and CEO Masayoshi Son’s optimistic AI vision, investor sentiment is cautious due to high-risk investments. This downturn impacted other Asian tech giants like TSMC and Foxconn, reflecting global market volatility and a focus on short-term momentum.

Bluesky is pivoting from a direct X competitor to a community-focused platform inspired by Reddit. COO Rose Wang stated the goal is not to replicate past social media but to evolve into a useful discovery mechanism beyond broad public feeds. This shift leverages its open AT Protocol to foster diverse applications and communities. Despite user engagement challenges and funding, Bluesky aims to improve video features and cautiously explore monetization beyond traditional advertising, prioritizing a community-centric vision.

Market momentum paused due to rising oil prices and Treasury yields amid Iran conflict concerns. Diplomatic efforts saw an Israel-Lebanon ceasefire, while Congress debated war powers. SpaceX’s $75 billion IPO looms with high valuation scrutiny. Corporate earnings showed mixed results, with Broadcom missing revenue and CrowdStrike seeing a dip despite beating estimates. Global health officials are monitoring infectious diseases ahead of a major sporting event.

Coinbase is launching “Pre-IPO Perps,” offering traders price exposure to private companies like SpaceX before their public listing. This new derivative product, settled in USDC, aims to tap into growing investor demand for early access to high-growth private entities. Accessible outside the U.S., it diversifies Coinbase’s offerings and revenue streams beyond cryptocurrencies, positioning itself as an “Everything Exchange.” Coinbase plans to expand this offering to other sectors.

On Thursday, investors rotated capital from AI hardware to healthcare and financials. Jim Cramer characterized this as a healthy rotation, not a collapse, with profit-taking in AI leaders and anticipated renewed investment. Healthcare saw gains in Eli Lilly and Johnson & Johnson, while financials surged with Goldman Sachs hitting an all-time high. Cramer viewed CrowdStrike’s decline as a buying opportunity, citing strong future contract potential.

Supabase has secured $500 million in funding at a $10.5 billion valuation, doubling its worth since its last round. This substantial investment highlights strong investor confidence in AI development infrastructure, with Supabase’s PostgreSQL-based platform proving crucial for AI-assisted coding and application scaling. The company is challenging established database providers and plans to use the funds to further fuel AI development.

Despite strong quarterly results and optimistic guidance, CrowdStrike, Broadcom, and Palo Alto Networks experienced post-earnings stock dips. This is attributed to heightened investor focus on AI growth stories and elevated expectations from recent tech rallies. Analysts remain largely positive, increasing price targets. The declines are seen as market consolidation and a reaction to unmet trading expectations, rather than a reflection of deteriorating fundamentals, with AI reinforcing the critical need for cybersecurity. Long-term investors are advised to view these pullbacks as potential opportunities.

Quantinuum debuted on Nasdaq with a $15.7 billion valuation, raising $1.68 billion. The company offers a full-stack quantum computing platform, serving diverse sectors. Despite a recent revenue dip, the company received significant government investment and benefits from broad industry interest in quantum technology’s potential to revolutionize fields like drug discovery and materials science.

Bitcoin faces significant downward pressure due to a faltering narrative and liquidity rotation into dynamic assets like semiconductors and SpaceX. Bitcoin ETFs are experiencing record net outflows, while regulatory clarity dims. MicroStrategy’s first Bitcoin sale in two years unsettled investors, triggering long liquidations. The market is closely watching for MicroStrategy’s next move, with analysts predicting a potential return to buying to stabilize sentiment. Despite current challenges, the four-year cycle suggests a potential bottom in late October.